TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Hemsö Medicinaren AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
101,490
|
88,396
|
88,232 |
Financial expenses |
48,960
|
17,630
|
11,863 |
Earnings before taxes |
11,019
|
20,775
|
29,446 |
EBITDA |
67,318
|
54,045
|
57,632 |
Total assets |
1,313,492
|
980,762
|
854,437 |
Current assets |
262,877
|
2,275
|
56 |
Current liabilities |
45,573
|
235,913
|
149,073 |
Equity capital |
226,290
|
291,711
|
85,044 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.2%
|
29.7%
|
10.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
10.9%
|
23.5%
|
33.4% |
Return on assets (ROA) |
4.6%
|
3.9%
|
4.8% |
Current ratio |
576.8%
|
1.0%
|
0.0% |
Return on equity (ROE) |
4.9%
|
7.1%
|
34.6% |
Change turnover |
13,094
|
164
|
-1,297 |
Change turnover % |
15%
|
0%
|
-1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.